IFF has entered into an agreement to acquire Health Wright Products, a provider of formulation and capsule manufacturing services for the dietary supplement industry.
The Oregon-based company is a long-time business partner of IFF’s Health & Biosciences probiotics business. It manufactures custom formulations, and delivers encapsulation and packaging designed to meet industry requirements for probiotic products.
The acquisition will bring these capabilities to IFF’s probiotics, natural extracts and botanicals businesses, allowing for development of custom formulation and combination products through joint capabilities.
The company’s more than 225 employees will continue retain their positions after the sale.
“Today’s announcement is driven by our commitment to enhance long-term value to our partners and customers. Producing thousands of unique and complex formulations for the industry’s most trusted brands, Health Wright Products formulation and finished format abilities will allow us to develop new and customised solutions and formats for a broad base of customers,” said Simon Herriott, President, IFF’s Health & Biosciences division.
“We look forward to joining IFF’s Health & Biosciences division. Health Wright Products best-in-class quality manufacturing and formulation capabilities, combined with the strong biotech innovation pipeline of IFF’s Health & Biosciences, is an exciting proposition for our customers and employees,” said Mark Wright, President, Health Wright Products.
